Literature DB >> 22082594

Isolated squamous cell carcinoma of the orbital apex.

Jeffrey L Peckinpaugh1, Bryan J Winn, Rhonda V Barrett, Douglas W Jacobsen, Bryan S Sires, Dale R Meyer, Arash Jian-Amadi.   

Abstract

A 43-year-old woman (Case 1), 63-year-old man (Case 2), and a 67-year-old man (Case 3) presented with diplopia (Cases 1, 2, and 3) and upper-eyelid ptosis (Cases 1 and 3). The cases had preceding cranial nerve V1 disturbances ranging from 3 months to 8 years. Each demonstrated complete internal ophthalmoplegia and external ophthalmoplegia. No case had a cutaneous squamous cell carcinoma (SCC) on presentation or by history. Imaging revealed isolated orbital apex masses. Tumor biopsies revealed SCCs of various differentiations. Systemic workup revealed no extraorbital malignancy. All received radiation therapy, and 2 patients underwent adjuvant chemotherapy. One patient is alive since diagnosis (49 months). In Case 2, SCC developed in the contralateral orbit, and the patient died 19 months after diagnosis; and Case 3 died 12 months after diagnosis. These isolated cases of orbital SCC may have arisen from orbital choristomatous squamous epithelium, may represent de novo or metastatic tumors, or may be manifestations of occult perineural spread.

Entities:  

Mesh:

Year:  2012        PMID: 22082594     DOI: 10.1097/IOP.0b013e31822ddd91

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Perineural Spread of Cutaneous Squamous Cell Carcinoma Manifesting as Ophthalmoplegia.

Authors:  Antigoni Koukkoulli; Nikolas Koutroumanos; Desmond Kidd
Journal:  Neuroophthalmology       Date:  2015-06-17

2.  [Unexpected outcome in entropion lower eyelid repair].

Authors:  J Maaß; F Sommer
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

3.  Invasive Orbital Squamous Cell Carcinoma in a Patient with Multiple Myeloma.

Authors:  Narges Karrabi; Kiana Hassanpour; Noushin Afshar Moghaddam; Faezeh Khorasanizadeh; Sadid Hooshmandi; Amirreza Veisi
Journal:  Case Rep Ophthalmol Med       Date:  2022-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.